Intestinal flora: a potential pathogenesis mechanism and treatment strategy for type 1 diabetes mellitus

Type 1 diabetes mellitus (T1DM) is a chronic autoimmune disease characterized by destruction of pancreatic β-cells, leading to insulin deficiency and hyperglycemia, and its incidence is increasing year by year. The pathogenesis of T1DM is complex, mainly including genetic and environmental factors....

Full description

Saved in:
Bibliographic Details
Main Authors: Shengnan Huang, Fangfang Li, Chunhua Quan, Dan Jin
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Gut Microbes
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/19490976.2024.2423024
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850225090049867776
author Shengnan Huang
Fangfang Li
Chunhua Quan
Dan Jin
author_facet Shengnan Huang
Fangfang Li
Chunhua Quan
Dan Jin
author_sort Shengnan Huang
collection DOAJ
description Type 1 diabetes mellitus (T1DM) is a chronic autoimmune disease characterized by destruction of pancreatic β-cells, leading to insulin deficiency and hyperglycemia, and its incidence is increasing year by year. The pathogenesis of T1DM is complex, mainly including genetic and environmental factors. Intestinal flora is the largest microbial community in the human body and plays a very important role in human health and disease. In recent years, more and more studies have shown that intestinal flora and its metabolites, as an environmental factor, regulate the development of T1DM through various mechanisms such as altering the intestinal mucosal barrier, influencing insulin secretion and body immune regulation. Intestinal flora transplantation, probiotic supplementation, and other approaches to modulate the intestinal flora appear to be potential therapeutic approaches for T1DM. This article reviews the dysbiosis of the intestinal flora in T1DM, the potential mechanisms by which the intestinal flora affects T1DM, as well as discusses potential approaches to treating T1DM by intervening in the intestinal flora.
format Article
id doaj-art-3227733c4e1c46aea4b8f167bc938b9f
institution OA Journals
issn 1949-0976
1949-0984
language English
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series Gut Microbes
spelling doaj-art-3227733c4e1c46aea4b8f167bc938b9f2025-08-20T02:05:28ZengTaylor & Francis GroupGut Microbes1949-09761949-09842024-12-0116110.1080/19490976.2024.2423024Intestinal flora: a potential pathogenesis mechanism and treatment strategy for type 1 diabetes mellitusShengnan Huang0Fangfang Li1Chunhua Quan2Dan Jin3Immunology Biology Key Laboratory, Yanbian University, Yanji, ChinaImmunology Biology Key Laboratory, Yanbian University, Yanji, ChinaCentral Laboratory, The Affiliated Hospital of Yanbian University, Yanji, ChinaImmunology Biology Key Laboratory, Yanbian University, Yanji, ChinaType 1 diabetes mellitus (T1DM) is a chronic autoimmune disease characterized by destruction of pancreatic β-cells, leading to insulin deficiency and hyperglycemia, and its incidence is increasing year by year. The pathogenesis of T1DM is complex, mainly including genetic and environmental factors. Intestinal flora is the largest microbial community in the human body and plays a very important role in human health and disease. In recent years, more and more studies have shown that intestinal flora and its metabolites, as an environmental factor, regulate the development of T1DM through various mechanisms such as altering the intestinal mucosal barrier, influencing insulin secretion and body immune regulation. Intestinal flora transplantation, probiotic supplementation, and other approaches to modulate the intestinal flora appear to be potential therapeutic approaches for T1DM. This article reviews the dysbiosis of the intestinal flora in T1DM, the potential mechanisms by which the intestinal flora affects T1DM, as well as discusses potential approaches to treating T1DM by intervening in the intestinal flora.https://www.tandfonline.com/doi/10.1080/19490976.2024.2423024Type 1 diabetes mellitusintestinal florashort-chain fatty acidsautoimmune disease
spellingShingle Shengnan Huang
Fangfang Li
Chunhua Quan
Dan Jin
Intestinal flora: a potential pathogenesis mechanism and treatment strategy for type 1 diabetes mellitus
Gut Microbes
Type 1 diabetes mellitus
intestinal flora
short-chain fatty acids
autoimmune disease
title Intestinal flora: a potential pathogenesis mechanism and treatment strategy for type 1 diabetes mellitus
title_full Intestinal flora: a potential pathogenesis mechanism and treatment strategy for type 1 diabetes mellitus
title_fullStr Intestinal flora: a potential pathogenesis mechanism and treatment strategy for type 1 diabetes mellitus
title_full_unstemmed Intestinal flora: a potential pathogenesis mechanism and treatment strategy for type 1 diabetes mellitus
title_short Intestinal flora: a potential pathogenesis mechanism and treatment strategy for type 1 diabetes mellitus
title_sort intestinal flora a potential pathogenesis mechanism and treatment strategy for type 1 diabetes mellitus
topic Type 1 diabetes mellitus
intestinal flora
short-chain fatty acids
autoimmune disease
url https://www.tandfonline.com/doi/10.1080/19490976.2024.2423024
work_keys_str_mv AT shengnanhuang intestinalfloraapotentialpathogenesismechanismandtreatmentstrategyfortype1diabetesmellitus
AT fangfangli intestinalfloraapotentialpathogenesismechanismandtreatmentstrategyfortype1diabetesmellitus
AT chunhuaquan intestinalfloraapotentialpathogenesismechanismandtreatmentstrategyfortype1diabetesmellitus
AT danjin intestinalfloraapotentialpathogenesismechanismandtreatmentstrategyfortype1diabetesmellitus